Abstract
Non-Alcahoolic Fatty Liver Disease prevalence is around one-fourth worldwide, being considered the hepatic component of metabolic syndrome. It is characterized by fat accumulation in liver (steatosis) and can develop to non-alcoholic steato-hepatitis (NASH). Brain derived neurotrophic factor (BDNF) signaling cascade requires neurotrophic receptor tyrosine kinase (NTRK2), mediating neuron …